Legend Biotech Corporation (LEGN)

Legend Biotech Stock Price & Analysis


LEGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$30.76 - $58.00
Previous Close$40.28
Average Volume (3M)766.62K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$462.30M
Total Debt (Recent Filing)$2.56M
P/E Ratio-16.8
Next EarningsNov 21, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-2.40
Shares Outstanding167,402,792
Standard Deviation0.14
10 Day Avg. Volume754,883
30 Day Avg. Volume766,621
P/B Ratio14.64
P/S Ratio85.57
P/CF RatioN/A
P/FCF Ratio-29.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside64.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Legend Biotech’s price range in the past 12 months?
Legend Biotech lowest stock price was $30.75 and its highest was $58.00 in the past 12 months.
    What is Legend Biotech’s market cap?
    Currently, no data Available
    When is Legend Biotech’s upcoming earnings report date?
    Legend Biotech’s upcoming earnings report date is Nov 21, 2022 which is in 48 days.
      How were Legend Biotech’s earnings last quarter?
      Legend Biotech released its earnings results on Sep 02, 2022. The company reported -$0.325 earnings per share for the quarter, missing the consensus estimate of -$0.31 by -$0.015.
        Is Legend Biotech overvalued?
        According to Wall Street analysts Legend Biotech’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Legend Biotech pay dividends?
          Legend Biotech does not currently pay dividends.
          What is Legend Biotech’s EPS estimate?
          Legend Biotech’s EPS estimate is -$0.38.
            How many shares outstanding does Legend Biotech have?
            Legend Biotech has 162,870,850 shares outstanding.
              What happened to Legend Biotech’s price movement after its last earnings report?
              Legend Biotech reported an EPS of -$0.325 in its last earnings report, missing expectations of -$0.31. Following the earnings report the stock price went down -1.368%.
                Which hedge fund is a major shareholder of Legend Biotech?
                Among the largest hedge funds holding Legend Biotech’s share is Bridgewater Associates, LP. It holds Legend Biotech’s shares valued at 31M.


                  Legend Biotech Stock Analysis

                  Smart ScoreOutperform
                  The Legend Biotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Legend Biotech Corporation

                  Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Its other pipeline products include LB1910, LB1909, LB1903, and others. Geographically, the company generates a majority of its revenue from North America.

                  Similar Stocks
                  Price & Change
                  Gilead Sciences
                  Vertex Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis